Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
Nonivamide (Capsaicin Analog): TRPV1 Agonist in Neuroimmu...
2025-09-26
Explore how Nonivamide, a capsaicin analog and TRPV1 receptor agonist, uniquely bridges neuroimmune modulation and targeted cancer research. This article offers a novel, integrated perspective on Nonivamide’s anti-proliferative and inflammation-regulating mechanisms for advanced oncology and neurobiology applications.
-
Phosbind Acrylamide: Precision Phosphorylation Analysis W...
2025-09-25
Discover how Phosbind Acrylamide, a phosphate-binding reagent, revolutionizes phosphorylation analysis by enabling antibody-free detection and mechanistic insights into complex signaling pathways. This article uniquely explores processive multisite phosphorylation and dynamic signaling events, advancing beyond standard workflows.
-
Nonivamide: Precision Targeting of TRPV1 for Cancer and N...
2025-09-24
Explore how Nonivamide, a potent capsaicin analog, uniquely leverages TRPV1 receptor agonism for advanced cancer research and neuroimmune modulation. Discover mechanistic insights, translational applications, and new perspectives not covered in existing literature.
-
AZD0156: Unraveling ATM Inhibition and Metabolic Adaptati...
2025-09-23
Explore how AZD0156, a potent and selective ATM kinase inhibitor, not only modulates DNA damage response but also reveals novel metabolic vulnerabilities in cancer cells. This article highlights recent research on ATM inhibition, metabolic adaptation, and the implications for cancer therapy research.
-
br Introduction Alzheimer s disease AD is
2025-03-03

Introduction Alzheimer's disease (AD) is a neurodegenerative disorder and the leading cause of dementia. It is characterized by progressive and irreversible damage to different Trequinsin hydrochloride areas, resulting in cognitive impairment and behavioral changes (O'Neill, 2013, De Strooper an
-
br Development of lorlatinib from crizotinib to a clinical
2025-03-03

Development of lorlatinib from crizotinib (1) to a clinical candidate (6) Xalkori (1, PF-02341066, crizotinib), was the first-in-class ALK inhibitor approved by the Unites States Food and Drug Administration (FDA) in 2011 as a first-line treatment for ALK+- NSCLC patients. This section describes
-
An important and well documented pathway involved in
2025-03-03

An important and well-documented pathway involved in cellular growth and proliferation is the mTOR-mediated synthesis of proteins and lipids [7,13,14]. Although found to be tissue specific or context specific regulation, it has always been observed that either one or both the mTOR complexes regulate
-
The reduced IFN production seen with BPAL primed splenocytes
2025-03-03

The reduced IFNγ production seen with BPAL10-primed splenocytes could potentially be attributed to the impaired intracellular survival of B. pertussis, thereby leading to a weakened induction of cell-mediated immunity. Earlier studies have suggested an antimicrobial role of IFNγ in mediating the el
-
ADA catalyzes the deamination of adenosine and deoxyadenosin
2025-03-03

ADA catalyzes the deamination of adenosine and deoxyadenosine into their respective inosine nucleoside (Cristalli et al., 2001). This conversion is an initial step in a series of reactions responsible for lymphocyte proliferation and differentiation. Moreover, ADA is considered an indicator of cellu
-
Because activation of HT A receptor is capable of facilitati
2025-03-03

Because activation of 5-HT2A receptor is capable of facilitating dopamine cell activity and dopamine release (Bortolozzi et al., 2003), and this action of dopamine is known to mediate rat maternal behavior, especially maternal motivation (Afonso et al., 2007, Febo et al., 2010, Li and Fleming, 2003,
-
The most potent compounds within the
2025-03-03

The most potent compounds within the current series of compounds were therefore , , , , and , with Ramiprilat possessing the best selectivity towards the lyase reaction in comparison to the hydroxylase reaction, indeed, this compound was found to possess an IC value of 1210nM against the 17α-OHas
-
Mistletoe is universal name for various species of parasitic
2025-03-03

Mistletoe is universal name for various species of parasitic plant which grows attached to and within the branches of host trees such as apple, elm, oak and pine. Mistletoe extract prepared from Viscum album, a species of mistletoe in the family Santalaceae, is generally known as European mistletoe
-
br Extracellular domain architecture The
2025-03-01

Extracellular domain architecture The extracellular region of GABAB receptor exists in a heterodimeric configuration regardless of interactions within the rest of the protein (Geng et al., 2012, Liu et al., 2004, Nomura et al., 2008). The extracellular domains of the GABAB1 and GABAB2 subunits ar
-
The potent inhibition of aromatase by ziram
2025-03-01

The potent inhibition of aromatase by ziram indeed caused the lower estradiol production in JEG-3 cells (Fig. 4), confirming that ziram can penetrate the cell membrane to get into the cells to act. However, the treatment of ziram did not lower progesterone production in JEG-3 cells (Fig. 4), indicat
-
Hepatoid adenocarcinoma closely resembles HCC and in some ca
2025-03-01

Hepatoid adenocarcinoma closely resembles HCC and in some cases can be indistinguishable morphologically. Hepatoid adenocarcinoma is an aggressive neoplasm, and metastasis to the liver is common [12]. Gastric metastasis from HCC has also been reported [27]. Distinguishing hepatoid adenocarcinoma fro
15677 records 19/1046 page Previous Next First page 上5页 1617181920 下5页 Last page